CIK 0001743881 · Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Shareholder vote results
- 4 Planned sale Director sold 4,292 shares at $40.00 ($171,680)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Executive Officer sold 101,156 shares at an average $33.38 ($3,376,741)
- 4 Shares withheld for taxes President and CFO gave up 21,317 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 4,780 shares (to pay taxes)
- 144 Insider Sale of Securities
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale 10% owner sold 6,000,000 shares at $34.20 ($205,200,000)
- 144 Insider Sale of Securities
- 4 Insider Changes in Ownership
- DEFA14A Proxy Proxy Materials
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 144 Insider Sale of Securities
- DEFA14A Proxy Proxy Materials
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 11 of 42 · 834 filings